How does tirzepatide ordering work at Hallandale Pharmacy?

Hallandale Pharmacy compounds tirzepatide Flex-Dose in 1 mL, 2 mL, 3 mL, and 4 mL multi-dose vials at 10 mg/mL, plus a Forte Flex-Dose at 4 mL and 15 mg/mL for higher-dose steps. The tiered concentration structure matters: a program that escalates from low to high doses may move between standard and Forte SKUs, and the per-vial economics of each step can differ. Concentrations and availability should be confirmed directly with Hallandale, as their formulary can change.

As of 2026, compounded tirzepatide requires an individual prescription with documented clinical justification. The FDA declared the tirzepatide shortage resolved in early 2025, after which 503A compounders may only prepare patient-specific prescriptions with a documented medical need for the compounded form. This requirement applies across all compounders, not just Hallandale, and prescribers need appropriate documentation on file.

The dominant pitfall is opaque per-step pricing. Hallandale does not list per-vial tirzepatide rates publicly — clinics call for a quote. When a protocol spans the Flex-Dose and Forte concentration tiers, a single blended quote can hide where the program loses margin at higher steps. The second pitfall is validation timing: a draw-volume error, a SIG written for the wrong step, or a prescriber not licensed in a patient's state should surface before the order is filled, not after.

Fizy Health is a multi-compounder 503A ordering platform that builds around these pressure points. Per-vial 503A cost shows on each catalog and cart line before checkout, so you can price each protocol step on a real number; the whole refill day goes into one validated clinic cart; and steady patients can move to auto-ship. Ordering through a single compounder like Hallandale means the relationship is direct — confirm the per-step rates, Forte SKU availability, and documentation requirements in a call before signing.